Indicator summary: Neutral (2 bullish, 2 bearish, 1 neutral). As of 2026-10-16, the close was $150.55: 3.8% above the 50-day average and 1.2% below the 200-day average, which is falling. RSI (14) is 66, in its neutral range. MACD is bullish after a cross in the last 10 days. The stock sits 47% of the way up its 52-week range of $134.26 to $169.27, on 0.8x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $145.06 | Price 3.8% above |
| 200-day average | $152.34 | Price 1.2% below, average falling |
| 50 vs 200-day | 50 below 200 | Death-cross alignment |
| RSI (14) | 66 | Neutral range |
| MACD (12, 26, 9) | +1.31 vs -0.41 | Bullish cross in the last 10 days |
| 52-week range | $134.26 to $169.27 | 47% of the way up the range |
| Volume vs 20-day average | 0.8x | Normal |
Base rates use YUM's own daily history since 1999; they describe the past, not a forecast.
As of 2026-10-16, YUM's 14-day RSI is 66, which is in the neutral range between 30 and 70.
No. YUM closed at $150.55 on 2026-10-16, 1.2% below its 200-day average of $152.34, which is falling. When it closed below its 200-day average (1,567 days), it was higher 63 trading days later 74% of the time, median +6.3%.
Yes. YUM closed at $150.55 on 2026-10-16, 3.8% above its 50-day average of $145.06. When it closed above its 50-day average (4,189 days), it was higher 63 trading days later 64% of the time, median +3.1%.
Yes, a bullish cross within the last 10 trading days. As of 2026-10-16 the MACD line is +1.31 against a signal line of -0.41, so MACD is bullish.
No. At $150.55 it sits 47% of the way up its 52-week range of $134.26 to $169.27, 11.1% below the high.
Neutral: 2 of 5 indicators are bullish and 2 bearish as of 2026-10-16 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Hold, from the chart signal model.
YUM analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.